Pharma & Biotech

The long wait for concrete validation appears to be over for InnoCan Pharma's stakeholders. The biotech firm has delivered a...

Facing intense competitive pressure, Danish pharmaceutical leader Novo Nordisk is executing a dramatic strategic pivot. With its shares down more...

The pharmaceutical sector has reached an unprecedented milestone as Eli Lilly becomes the first drugmaker to achieve a $1 trillion...

The investment case for Ocugen is under severe pressure as its stock experiences a dramatic downward spiral. With bearish investors...

Pharmaceutical titan Pfizer is aggressively reshaping its identity beyond being perceived as a pandemic beneficiary, making a substantial strategic commitment...

Despite posting impressive double-digit revenue growth and receiving votes of confidence from its leadership, Redcare Pharmacy's stock continues its relentless...

BioNxt Solutions has achieved a pivotal regulatory milestone that could fundamentally reshape its long-term commercial prospects. The biotechnology firm has...

Despite recent market jitters affecting investor sentiment, the underlying financial performance of French vaccine specialist Valneva tells a different story....

BioAtla Inc has successfully secured fresh capital, but the terms of the financing have raised significant questions about the company's...

Castle Biosciences, a prominent player in the diagnostic sector, is witnessing a remarkable surge in its stock value, with shares...